Assessing MicroVision (MVIS) Valuation After Recent Share Price Volatility

MicroVision (MVIS) shares caught some attention this week as investors reassessed the company's long-term outlook in the lidar and perception solutions space. The stock has shifted notably in the past month.

See our latest analysis for MicroVision.

MicroVision’s share price has been on a rollercoaster lately, sliding over 21% in the last month even as excitement builds around its lidar innovations. Still, when you take a step back, the company’s one-year total shareholder return sits in positive territory. This is a notable contrast to longer-term losses, suggesting recent momentum could be shifting as investors weigh both short-term risks and new tech developments.

If you’re curious about other emerging names beyond lidar, this could be a great moment to discover fast growing stocks with high insider ownership

With shares trading far below analyst targets and recent performance diverging from longer-term returns, the debate now centers on valuation. Is MicroVision an overlooked bargain, or is the market fully accounting for its potential growth?

Advertisement

Most Popular Narrative: 98% Undervalued

Against a last close of $0.94, the most watched valuation narrative, authored by TheWallstreetKing, pegs MicroVision's fair value at $60. The thesis is built around a dramatic pivot to a dual-engine business model aiming for explosive multi-vertical growth. Here is a pivotal segment:

The defense revenue acts as a stabilizing foundation. We assume MVIS captures a conservative five to seven percent of the drone sensor TAM, which is a reasonable assumption given their technological differentiation and strategic positioning. For automotive, we model the successful capture of two major OEM platforms by the 2028 model year, which is aggressive but plausible given the new CEO's background and the company's technological readiness.

Read the complete narrative.

What fuels this bold price target? It is not just about new contracts or hype. It is the radical growth mix hidden in revenue streams, backed by high-margin defense projections and a tech roadmap that is anything but ordinary. MicroVision’s transformation story could surprise the market. Want to see which bets underlie this $60 target?

Result: Fair Value of $60 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, steep competition or missing major defense contracts could quickly challenge MicroVision's dual-engine thesis and stall its momentum in both key markets.

Find out about the key risks to this MicroVision narrative.

Build Your Own MicroVision Narrative

Feeling inspired to dig deeper or challenge these forecasts? You can explore the numbers yourself and shape your own narrative in just a few minutes. Do it your way

A great starting point for your MicroVision research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.

Looking for More Investment Ideas?

Get ahead of the curve and find overlooked opportunities by checking out handpicked groups of stocks that could position your portfolio for outsized growth.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqCM:MVIS

MicroVision

Develops and commercializes lidar sensors and perception solutions in the United States, Germany, and internationally.

Medium-low risk with mediocre balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1155.3% undervalued
50 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7719.9% undervalued
69 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9217.2% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$1907.4% undervalued
24 users have followed this narrative
0 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

BR
Brunhilde_Wagner
CPRT logo
Brunhilde_Wagner on Copart ·

Compounder to Cash Generator in Real Time

Fair Value:US$2710.3% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.9% undervalued
6 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.3% undervalued
85 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.8% undervalued
193 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.7% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0
AN
CSMG3 logo
andre_k1tsg on Companhia de Saneamento de Minas Gerais ·

Gostei

0
|
0